Article
Gene expression profiling-based risk prediction and profiles of immune infiltration in diffuse large B-cell lymphoma
7 Jan 2021
Abstract excerpt
The clinical risk stratification of diffuse large B-cell lymphoma (DLBCL) relies on the International Prognostic Index (IPI) for the identification of high-risk disease. Recent studies suggest that the immune microenvironment plays a role in treatment response prediction and survival in DLBCL. This study developed a risk prediction model and evaluated the model's biological implications in association with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
